Literature DB >> 16798250

Acute exacerbation of interstitial fibrosis after pulmonary resection.

Mustafa Yüksel1, Mehmet Oguzhan Ozyurtkan, Korkut Bostanci, Rengin Ahiskali, Nihat Kodalli.   

Abstract

Idiopathic pulmonary fibrosis is a chronic diffuse lung disease of unknown cause, and a risk factor for increasing morbidity and mortality after lung resection. Acute exacerbation of idiopathic pulmonary fibrosis after lung surgery for lung cancer is rare. The outcome is unsatisfactory despite therapy. We report two cases of acute exacerbation of idiopathic pulmonary fibrosis after resection for lung cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16798250     DOI: 10.1016/j.athoracsur.2005.09.036

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  12 in total

Review 1.  Acute exacerbations of idiopathic pulmonary fibrosis.

Authors:  Harold R Collard; Bethany B Moore; Kevin R Flaherty; Kevin K Brown; Robert J Kaner; Talmadge E King; Joseph A Lasky; James E Loyd; Imre Noth; Mitchell A Olman; Ganesh Raghu; Jesse Roman; Jay H Ryu; David A Zisman; Gary W Hunninghake; Thomas V Colby; Jim J Egan; David M Hansell; Takeshi Johkoh; Naftali Kaminski; Dong Soon Kim; Yasuhiro Kondoh; David A Lynch; Joachim Müller-Quernheim; Jeffrey L Myers; Andrew G Nicholson; Moisés Selman; Galen B Toews; Athol U Wells; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2007-06-21       Impact factor: 21.405

2.  Clinical results of sublobar resection versus lobectomy or more extensive resection for lung cancer patients with idiopathic pulmonary fibrosis.

Authors:  Seok Joo; Dong Kwan Kim; Hee Je Sim; Geun Dong Lee; Su Kyung Hwang; Sehoon Choi; Hyeong Ryul Kim; Yong-Hee Kim; Seung-Il Park
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

3.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

4.  Idiopathic interstitial pneumonias: do HRCT criteria established by ATS/ERS/JRS/ALAT in 2011 predict disease progression and prognosis?

Authors:  Chiara Romei; Laura Tavanti; Paola Sbragia; Annalisa De Liperi; Laura Carrozzi; Ferruccio Aquilini; Antonio Palla; Fabio Falaschi
Journal:  Radiol Med       Date:  2015-03-06       Impact factor: 3.469

5.  Acute exacerbation of subclinical pulmonary fibrosis after red blood cell transfusion: a case report.

Authors:  Matthew Woodske; Michael P Donahoe; Mark Yazer; Janet S Lee
Journal:  Transfusion       Date:  2011-08-09       Impact factor: 3.157

6.  Predictive factors for postoperative acute exacerbation of interstitial pneumonia combined with lung cancer.

Authors:  Yasushi Shintani; Mitsunori Ohta; Teruo Iwasaki; Naoki Ikeda; Emiko Tomita; Kunimitsu Kawahara; Yuko Ohno
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-04-18

7.  Impact of FDG-PET on the Detection of Patients with Lung Cancer at High Risk for ILD.

Authors:  Paul Flechsig; Olena Hural; Michael Kreuter; Martin Eichhorn; Gudula HEUßEL; Christos Sachpekidis; Hans-Ulrich Kauczor; Uwe Haberkorn; Claus Peter Heussel; Monika Eichinger
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

Review 8.  Determinants of initiation and progression of idiopathic pulmonary fibrosis.

Authors:  Robert Matthew Kottmann; Christopher M Hogan; Richard P Phipps; Patricia J Sime
Journal:  Respirology       Date:  2009-09       Impact factor: 6.424

9.  Approach to acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Hammad Bhatti; Ankur Girdhar; Faisal Usman; James Cury; Abubakr Bajwa
Journal:  Ann Thorac Med       Date:  2013-04       Impact factor: 2.219

10.  Pirfenidone treatment of idiopathic pulmonary fibrosis.

Authors:  Ye Gan; Erica L Herzog; Richard H Gomer
Journal:  Ther Clin Risk Manag       Date:  2011-02-08       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.